110582-32-6

Basic information

• Product Name: *,R^*)>-4,9-dihydro-β-hydroxy-α-<(methoxycarbonyl)amino>-4,6-dimethyl-9-oxo-1H-imidazo<1,2-a>purine-7-butanoic acid methyl ester
• CAS NO: 110582-32-6
• Molecular Weight: 392.371
• Mol File: 110582-32-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: *,R^*)>-4,9-dihydro-β-hydroxy-α-<(methoxycarbonyl)amino>-4,6-dimethyl-9-oxo-1H-imidazo<1,2-a>purine-7-butanoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: *,R^*)>-4,9-dihydro-β-hydroxy-α-<(methoxycarbonyl)amino>-4,6-dimethyl-9-oxo-1H-imidazo<1,2-a>purine-7-butanoic acid methyl ester(110582-32-6)
• EPA Substance Registry System: *,R^*)>-4,9-dihydro-β-hydroxy-α-<(methoxycarbonyl)amino>-4,6-dimethyl-9-oxo-1H-imidazo<1,2-a>purine-7-butanoic acid methyl ester(110582-32-6)

Safety Data

• Hazardous Substances Data: 110582-32-6(Hazardous Substances Data)

Upstream product

• 110658-45-2 <4R-<4α(S^*),5β>>-5-<1-benzyl-4,9-dihydro-4,6-dimethyl-9-oxo-1H-imidazo<1,2-a>purin-7-yl>-α-<(methoxycarbonyl)amino>-2-oxo-1,3-dioxolane-4-acetic acid methyl ester 
• 110658-44-1 αS-(αR^*,βS^*,γS^*)-1benzyl-4,9-dihydro-β,γ-dihydroxy-α-<(methoxycarbonyl)amino>-4,6-dimethyl-9-oxo-1H-imidazo<1,2-a>purine-7-butanoic acid methyl ester 
• 96854-31-8 -4-<1-Benzyl-4,9-dihydro-4,6-dimethyl-9-oxo-1H-imidazo<1,2-a>purin-7-yl>-2-<(methoxycarbonyl)amino>-3-butenoic Acid Methyl Ester 
• 499207-72-6 4-[3-(3,4-diacetoxy-5-acetoxymethyl-tetrahydro-furan-2-yl)-4,6-dimethyl-8-oxo-4,8-dihydro-3H-1,3,4,5,7a-pentaaza-s-indacen-7-yl]-2-methoxycarbonylamino-but-3-enoic acid methyl ester 
• 189103-75-1 (αS,βR,γR)-β,γ-dihydroxy-α-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-[2,3,5-tris-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]-4,9-dihydro-3H-imidazo[1,2-a]purine-7-butanoic acid methyl ester 
• 189103-81-9 (αS,βS)-β-hydroxy-α-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-[2,3,5-tris-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]-4,9-dihydro-3H-imidazo[1,2-a]purine-7-butanoic acid methyl ester 
• 189103-74-0 [S-(E)]-4-[4,6-dimethyl-9-oxo-3-[2,3,5-tris-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]-4,9-dihydro-3H-imidazo[1,2-a]purin-7-yl]-2-[(methoxycarbonyl)amino]-3-butenoic acid methyl ester 
• 117136-12-6 7-iodo-4,6-dimethyl-3-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-4,9-dihydro-3H-imidazo<1,2-a>purin-9-one 
• 189103-83-1 (αS,βS)-α-[(methoxycarbonyl)amino]-β-hydroxy-4,6-dimethyl-9-oxo-3-β-D-ribofuranosyl-4,9-dihydro-3H-imidazo[1,2-α]purine-7-butanoic acid methyl ester 

Relevant articles and documents

SYNTHESIS OF OPTICALLY ACTIVE FORMS OF HYDROXY-Y BASE, THE MINOR COMPONENT OF RAT LIVER PHENYLALANINE TRANSFER RIBONUCLEIC ACID

-β-Hydroxywybutine (6) and its -isomer (9) have been synthesized as the most probable alternatives for hydroxy-Y base isolated from rat liver phenylalanine tRNA.

Synthesis of β-hydroxywybutines, the most probable alternatives for the hypermodified base of rat liver phenylalanine transfer ribonucleic acid

Deoxygenation of the 1,2-glycol (±)-5 was achieved at the position adjacent to the heterocycle through the cyclic carbonate (±)-14, providing the monohydroxy compound 6. This new method of regioselective deoxygenation was employed for the first synthesis